• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各类物质使用障碍患者中重度抑郁发作的生存概率及预测因素

Survival Probabilities and Predictors of Major Depressive Episode Incidence Among Individuals With Various Types of Substance Use Disorders.

作者信息

Hassan Ahmed N, Le Foll Bernard

机构信息

Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

出版信息

J Clin Psychiatry. 2021 Jul 27;82(5):20m13637. doi: 10.4088/JCP.20m13637.

DOI:10.4088/JCP.20m13637
PMID:34320696
Abstract

This study aimed to estimate the survival probabilities related to the occurrence of major depressive episodes (MDEs) after the onset of substance use disorders (SUDs) using data from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 was used to diagnose SUD, and psychiatric diagnoses were based on the , Fifth Edition. Individuals with incidents of various SUDs with no prior history of MDEs (n = 5,987 with alcohol use disorder [AUD], 1,353 with cannabis use disorder [CUD], 351 with opioid use disorder [OUD], 827 with stimulant use disorder [STUD], and 5,363 with nicotine use disorder [NUD]) were included. The survival probabilities of these groups were compared to those of a control group without an SUD (n = 20,034). Outcome measures included the number of years from the age at SUD onset until MDE occurrence or the time of the interview. The probabilities of experiencing MDEs after 1 year were 3.56%, 4.80%, 7.78%, 8.46%, and 5.31% for AUD, CUD, OUD, STUD, and NUD, respectively. The groups differed statistically significantly from each other and from the control group ( < .0001). Individuals with AUD and STUD, respectively, had a lower and higher probability of having an MDE compared to those with other SUDs. Young age, family history of depression, anxiety disorder presence, and failure to achieve full remission consistently predicted an MDE for all substances. The findings highlight that users of all studied substances have an increased probability of having an MDE over the lifespan.

摘要

本研究旨在利用2012 - 2013年全国酒精及相关疾病流行病学调查三期的数据,估计物质使用障碍(SUDs)发病后与重度抑郁发作(MDEs)发生相关的生存概率。使用酒精使用障碍及相关残疾访谈表-5来诊断SUDs,精神疾病诊断基于《精神疾病诊断与统计手册》第五版。纳入了各类SUDs发病且无MDEs既往史的个体(n = 5987例酒精使用障碍[AUD]、1353例大麻使用障碍[CUD]、351例阿片类物质使用障碍[OUD]、827例兴奋剂使用障碍[STUD]以及5363例尼古丁使用障碍[NUD])。将这些组的生存概率与无SUDs的对照组(n = 20034)进行比较。结局指标包括从SUD发病年龄到MDE发生或访谈时间的年数。AUD、CUD、OUD、STUD和NUD在1年后发生MDEs的概率分别为3.56%、4.80%、7.78%、8.46%和5.31%。这些组之间以及与对照组在统计学上有显著差异(P <.0001)。与其他SUDs患者相比,AUD和STUD患者发生MDE的概率分别较低和较高。年轻、有抑郁症家族史、存在焦虑障碍以及未能完全缓解一直是所有物质导致MDE的预测因素。研究结果突出表明,所有研究物质的使用者在一生中发生MDE的概率都会增加。

相似文献

1
Survival Probabilities and Predictors of Major Depressive Episode Incidence Among Individuals With Various Types of Substance Use Disorders.各类物质使用障碍患者中重度抑郁发作的生存概率及预测因素
J Clin Psychiatry. 2021 Jul 27;82(5):20m13637. doi: 10.4088/JCP.20m13637.
2
Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.在美国成年人中,酒精使用障碍、大麻使用障碍和尼古丁依赖与同时存在的阿片类药物使用障碍的关联。
Exp Clin Psychopharmacol. 2023 Dec;31(6):998-1004. doi: 10.1037/pha0000649. Epub 2023 May 11.
3
Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.酒精、尼古丁、大麻和可卡因经常使用者中依赖的概率及相关因素:酒精及相关状况国家流行病学调查的同期和前瞻性分析
J Clin Psychiatry. 2016 Apr;77(4):e444-50. doi: 10.4088/JCP.14m09469.
4
Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.一生中尼古丁、酒精、大麻或可卡因依赖缓解的可能性和预测因素:来自国家酒精相关情况流行病学调查的结果。
Addiction. 2011 Mar;106(3):657-69. doi: 10.1111/j.1360-0443.2010.03194.x. Epub 2010 Nov 16.
5
Risk for Substance Use Disorders in young adulthood: Associations with developmental experiences of homelessness, foster care, and adverse childhood experiences.青壮年时期物质使用障碍风险:与无家可归、寄养和不良儿童经历的发展相关联。
Compr Psychiatry. 2020 Jul;100:152175. doi: 10.1016/j.comppsych.2020.152175. Epub 2020 Apr 13.
6
Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.与 2 型糖尿病和高血压患者物质使用障碍相关的医疗并发症:电子健康记录发现。
Addiction. 2019 Aug;114(8):1462-1470. doi: 10.1111/add.14607. Epub 2019 Apr 25.
7
Strong and weak cross-inheritance of substance use disorders in a nationally representative sample.在一个全国代表性样本中,物质使用障碍的强交叉遗传和弱交叉遗传。
Mol Psychiatry. 2022 Mar;27(3):1742-1753. doi: 10.1038/s41380-021-01370-0. Epub 2021 Nov 10.
8
Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.兴奋剂、酒精和大麻使用障碍对首发精神病的特定影响:2 年的功能和症状结果。
Psychol Med. 2017 Oct;47(14):2461-2471. doi: 10.1017/S0033291717000976. Epub 2017 Apr 20.
9
Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.人格障碍与酒精、药物和尼古丁使用障碍的3年病程
Arch Gen Psychiatry. 2011 Nov;68(11):1158-67. doi: 10.1001/archgenpsychiatry.2011.136.
10
Associations between subtypes of major depressive episodes and substance use disorders.重性抑郁发作亚型与物质使用障碍的相关性。
Psychiatry Res. 2011 Apr 30;186(2-3):248-53. doi: 10.1016/j.psychres.2010.10.003. Epub 2010 Oct 28.

引用本文的文献

1
Cannabis and psychopathology: 2024 Snapshot of a meandering journey.大麻与精神病理学:2024年曲折历程概览
Indian J Psychiatry. 2025 Mar;67(3):283-302. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_968_24. Epub 2025 Mar 14.
2
Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years.草药大麻与抑郁症:过去三年发表研究结果综述
Pharmaceuticals (Basel). 2024 May 27;17(6):689. doi: 10.3390/ph17060689.
3
Cannabis use and mood disorders: a systematic review.大麻使用与情绪障碍:一项系统综述。
Front Public Health. 2024 Apr 9;12:1346207. doi: 10.3389/fpubh.2024.1346207. eCollection 2024.
4
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis.伴有酒精使用障碍的重性抑郁障碍患者的治疗结局:一项 STAR*D 分析。
J Affect Disord. 2023 Oct 15;339:691-697. doi: 10.1016/j.jad.2023.07.049. Epub 2023 Jul 17.
5
Principal component regression analysis of familial psychiatric histories and suicide risk factors among adults with opioid use disorder.精神病史和自杀风险因素在有阿片类药物使用障碍的成年人中的主成分回归分析。
J Psychiatr Res. 2023 Mar;159:6-13. doi: 10.1016/j.jpsychires.2023.01.021. Epub 2023 Jan 11.
6
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.丁丙诺啡/纳洛酮和美沙酮对有处方类阿片使用障碍者抑郁症状的影响:一项实用随机对照试验。
Can J Psychiatry. 2023 Aug;68(8):572-585. doi: 10.1177/07067437221145013. Epub 2022 Dec 14.
7
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial.患者对标准美沙酮和灵活丁丙诺啡/纳洛酮护理模式的满意度:来自一项实用随机对照临床试验的结果。
J Addict Med. 2023;17(1):e49-e56. doi: 10.1097/ADM.0000000000001048. Epub 2022 Aug 2.